4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-011587
SVP & Chief Scientific Officer sold 2,426 shares at $82.94 ($201,212)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doberstein Stephen K SVP & Chief Scientific Officer | 2018-02-16 | Sale | −2,426 | $82.94 | $201,212 | 67,394 | D: show line 1 in the form |
| Open-market sales · 2,426 sh · avg $82.94 · $201,212 | |||||||
Loading xslF345X03/doc4.xml…